Ceftaroline approved for pneumonia, skin infections

FDA approved an NDA from Forest Laboratories Inc. (NYSE:FRX) for Teflaro ceftaroline to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infe...